
Brendan Murray
Ask VT AI
View News Summary
- Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
- Deadly sea mine explosions on Odesa beaches highlight ongoing danger from drifting mines deployed by both sides in the conflict.
- GE HealthCare navigates tariff pressures, reporting Q2 sales and profit gains amid strategic adaptations to mitigate supply chain risks.
5 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
- Deadly sea mine explosions on Odesa beaches highlight ongoing danger from drifting mines deployed by both sides in the conflict.
- GE HealthCare navigates tariff pressures, reporting Q2 sales and profit gains amid strategic adaptations to mitigate supply chain risks.
5 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Brendan Murray
News from Brendan Murray